BVS · Bioventus Inc
United States · RS rating 45 · As of 2026-11-03
| Price | 10.95 USD |
|---|---|
| 1-day change | -16.8% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 22 / 22 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 28 / 25 / 33 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -81.0% |
| Sales growth Q/Q | +13.9% |
| Distance from 52-week high | +28.3% |
| Market cap (USD) | $656.8M |